跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAPTIQOM 15 MICROGRAMOS/ML + 5 MG/ML COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TAPTIQOM 15 MICROGRAMOS/ML + 5 MG/ML COLIRIO EN SOLUCION
Approved
STANDARD
TAPTIQOM 15 MICROGRAMOS/ML + 5 MG/ML COLIRIO EN SOLUCION
Santen Oy
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 17, 2020
Approval ID
1cc4c618e34bb0dc
Company
Santen Oy
Type
Standard
Approval Details
Approval Id
1cc4c618e34bb0dc
Drug Cima Aemps Name
TAPTIQOM 15 MICROGRAMOS/ML + 5 MG/ML COLIRIO EN SOLUCION
Register Number
85656
Holder Company Name
Santen Oy
Marketing Company Name
Santen Pharmaceutical Spain S.L.
Holder Company Detail Path
/organization/santen-oy
Authorization Date
2020-12-17
Dosage Form
COLIRIO EN SOLUCIÓN
Dose
15 microgramos/ml + 5 mg/ml
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Santen Oy
Company Detail Path
/organization/santen-oy
Company Information
Pharmaceutical Company Name
Santen Oy
Country Name
Finland
City Name
københavn ø,hovedstaden,country_dk
Address
Østbanegade 123
Website
http://www.santen.fi
Active Ingredients
TIMOLOL MALEATO
6,84 mg/ml
TAFLUPROST
0,015 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 17, 2020
Approval ID
1cc4c618e34bb0dc
Type
Standard
Back to CIMA-AEMPS Approvals